Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study

Tacrolimus monotherapy is accepted as a feasible option during early post-liver transplantation as per current international consensus guidelines. However, its effects in the recent era of reduced tacrolimus (TAC) and mycophenolate mofetil (MMF) remain unclear. Liver recipients who either received T...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Deok Gie, Kim, Sung Hwa, Hwang, Shin, Hong, Suk Kyun, Ryu, Je Ho, Kim, Bong-Wan, You, Young Kyoung, Choi, Donglak, Kim, Dong-Sik, Nah, Yang Won, Cho, Jai Young, Kim, Tae-Seok, Hong, Geun, Joo, Dong Jin, Kim, Myoung Soo, Kim, Jong Man, Lee, Jae Geun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145025/
https://www.ncbi.nlm.nih.gov/pubmed/35628939
http://dx.doi.org/10.3390/jcm11102806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145025/
https://www.ncbi.nlm.nih.gov/pubmed/35628939
http://dx.doi.org/10.3390/jcm11102806

Ejemplares similares